Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/134794
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Macrophage-mediated cancer drug delivery |
Author: | Wang, H.F. Liu, Y. Yang, G. Zhao, C.X. |
Citation: | MATERIALS TODAY SUSTAINABILITY, 2021; 11-12:100055-1-100055-6 |
Publisher: | Elsevier |
Issue Date: | 2021 |
ISSN: | 2589-2347 2589-2347 |
Statement of Responsibility: | H.-F. Wang, Y. Liu, G. Yang, C.-X. Zhao |
Abstract: | Cell-mediated drug delivery systems have attracted significant research interest in the past years owing to their superior properties such as excellent biocompatibility, potential long circulation, intrinsic homing properties, and ability to permeate biological barriers. Macrophages, as one of the major phagocytes of the innate immune system, represent a promising target for cancer drug delivery because, on the one hand, they play critical roles in the tumor microenvironment in various stages of tumor progression and, on the other hand, they can be harnessed as Trojan horses for enhanced drug delivery. This article provides a mini-review of the different aspects of macrophages for cancer therapy including tumor-associated macrophages (TAMs) in the tumor microenvironment, novel cancer treatment targeting TAMs, and nanoparticle-loaded macrophages as tumor-infiltrating drug carriers. |
Keywords: | Drug carriers; Tumor microenvironment; Nanoparticles; Cancer therapy; Tumor targeting |
Rights: | © 2020 Elsevier Ltd. All rights reserved. |
DOI: | 10.1016/j.mtsust.2020.100055 |
Grant ID: | http://purl.org/au-research/grants/arc/FT140100726 http://purl.org/au-research/grants/arc/DP200101238 |
Published version: | http://dx.doi.org/10.1016/j.mtsust.2020.100055 |
Appears in Collections: | Chemical Engineering publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.